SAIPARENT / NSE / Biotechnology & Drugs
Sai Parenterals Ltd
1Y Price Trend
Key Information
Recommendations
Target High563.35
Target Low400
Target Mean0
Target Median0
Risk Metrics
Overall RiskBalanced risk
Board Risk36.62
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Sai Parenterals share price listed at ₹ 405 on the BSE, up 3.32% as against the IPO price of ₹ 392. Meanwhile, on NSE, Sai Parenterals stock opened 2.04% higher at ₹ 400.
Three IPOs—Amir Chand Jagdish Kumar Exports, Powerica, and Sai Parenterals—are closing for subscription on March 27. Amir Chand has received better traction, while Powerica shows muted demand. Overall subscription trends reflect cautious investor sentiment in the primary market amid volatility.
Sai Parenterals has raised ₹ 122.6 crore from anchor investors ahead of its IPO, opening for subscription on March 24, 2026. The IPO includes a fresh issue and an offer for sale, with shares priced between ₹ 372 and ₹ 392. Proceeds will fund capacity expansion and R&D.
© SharekeyX | Rusaka Technologies 2024-2026

